PMC:7291971 / 692-891 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T14","span":{"begin":101,"end":111},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T15","span":{"begin":177,"end":180},"obj":"GO:0008541"},{"id":"T50627","span":{"begin":101,"end":111},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T65425","span":{"begin":177,"end":180},"obj":"GO:0008541"}],"text":"s (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to bl"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":181,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"s (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to bl"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T8","span":{"begin":53,"end":62},"obj":"Chemical"},{"id":"T9","span":{"begin":101,"end":111},"obj":"Chemical"}],"attributes":[{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"s (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to bl"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":158,"end":169},"obj":"http://purl.obolibrary.org/obo/GO_0032259"}],"text":"s (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to bl"}